Assura PLC

Director's Dealing • Aug 13, 2019

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 9148I

Assura PLC

13 August 2019

13 August 2019

Assura plc

Exercise of Nil Cost Options under PSP

Assura plc ("Assura"), the leading primary care property investor and developer announces that on 12 August 2019, Jonathan Murphy exercised his 2016 PSP awards.

The table below shows the number of shares vesting to Mr Murphy, the number of shares sold to satisfy income tax and national insurance liabilities and the number of shares he will receive following the sale.

	Number of Shares awarded	Number of shares sold to satisfy income tax and national insurance liabilities	Additional shares sold	Number of shares after shares sold
Jonathan Murphy (CEO)	218,950	(102,907)	nil	116,044

The Remuneration Committee of Assura had previously agreed that sufficient shares may be sold by PDMRs to cover the arising income tax and national insurance liabilities. The relevant market price for taxation purposes is £0.651 per share.

As a result of the above, the increase in Mr Murphy's shareholding is as follows:

	Shareholding on 9 August 2019	Shareholding  post exercise
Jonathan Murphy (CEO)	2,393,349	2,509,393

Following the allotment of shares Mr Murphy transferred 98,250 shares into his SIPP. His total beneficial holding remains the same.

The Notification of Dealing Form for the PDMR can be found below.

This notification is made in accordance with the Market Abuse Regulation.

Notification of dealing form

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Jonathan Murphy

2

Reason for the notification

a)

Position/status

CEO

b)

Initial notification/ Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Assura plc

b)

LEI

21380026T19N2Y52XF72

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 10 pence each

GB00BVGBWW93

b)

Nature of the transaction

Vesting of share awards under PSP

c)

Price(s) and volume(s)

Price(s)	Volume(s)
£NIL GBP	218,950

d)

Aggregated information

-      Aggregated volume

-    Price

N/A

e)

Date of the transaction

12 August 2019

f)

Place of the transaction

XLON

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 10 pence each

GB00BVGBWW93

b)

Nature of the transaction

Sale of 102,907 shares to satisfy tax and national insurance liabilities.

c)

Price(s) and volume(s)

Price(s)	Volume(s)
£0.651 GBP	102,907

d)

Aggregated information

-      Aggregated volume

-    Price

Aggregate Price	Aggregate Volume	Aggregate Total
£0.651 GBP	102,907	£66,992.46

e)

Date of the transaction

13 August 2019

f)

Place of the transaction

XLON

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 10 pence each

GB00BVGBWW93

b)

Nature of the transaction

Transfer of 98,250 shares to Mr Murphy's SIPP.

c)

Price(s) and volume(s)

Price(s)	Volume(s)
£0.651 GBP	98,250

d)

Aggregated information

-      Aggregated volume

-    Price

Aggregate Price	Aggregate Volume	Aggregate Total
£0.651 GBP	98,250	£63,960.75

e)

Date of the transaction

13 August 2019

f)

Place of the transaction

XLON

- Ends -

For more information, please contact:

Assura plc	Tel: 01925 420660
Orla Ball, Company Secretary
David Purcell, Head of Financial Reporting
Finsbury	Tel: 0207 251 3801
Gordon Simpson

Notes to Editors

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities. At 31 March 2019, Assura's property portfolio was valued at £1,979 million.

Further information is available at www.assuraplc.com

*EPRA is a registered trademark of the European Public Real Estate Association.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHGGURURUPBGAW